Literature DB >> 11060543

Children with morphea have normal self-perception.

Y Uziel1, R M Laxer, B R Krafchik, R S Yeung, B M Feldman.   

Abstract

We evaluated the self-esteem and quality of life of 47 children with morphea with the use of the Harter self-perception profile for children and Visual Analog Scale. Most children with morphea have normal self-worth and a high quality of life. Morphea, like some other childhood chronic illnesses, does not impair self-esteem.

Entities:  

Mesh：

Year:  2000        PMID： 11060543     DOI： 10.1067/mpd.2000.108564

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  6 in total

1.  Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort.

Authors:  Daniel Condie; Daniel Grabell; Heidi Jacobe
Journal:  Arthritis Rheumatol       Date:  2014-12       Impact factor: 10.995

2.  Psychometric properties of the Children's Dermatology Life Quality Index in pediatric localized scleroderma.

Authors:  Kaveh Ardalan; Galen E Switzer; Christina K Zigler; Nicole M Hershey; Kathryn S Torok
Journal:  J Scleroderma Relat Disord       Date:  2018-03-20

3.  Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.

Authors:  Kaveh Ardalan; Christina K Zigler; Kathryn S Torok
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-06-07       Impact factor: 4.794

4.  Health-related quality of life in morphoea.

Authors:  N K Klimas; A D Shedd; I H Bernstein; H Jacobe
Journal:  Br J Dermatol       Date:  2015-04-08       Impact factor: 9.302

5.  Correlates of self-reported quality of life in adults and children with morphea.

Authors:  Shinjita Das; Ira Bernstein; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2014-02-16       Impact factor: 11.527

6.  A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.

Authors:  C K Zigler; K Ardalan; S Lane; K L Schollaert; K S Torok
Journal:  Br J Dermatol       Date:  2019-10-23       Impact factor: 9.302
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.